The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups

Journal of Heart and Lung Transplantation

Volumn 36, Issue 9, 2017, Pages 957-967

  Gall, Henning ^a,b   Felix, Janine F ^b   Schneck, Franziska K ^a   Milger, Katrin ^a,c   Sommer, Natascha ^a   Voswinckel, Robert ^a   Franco, Oscar H ^b   Hofman, Albert ^b,d   Schermuly, Ralph T ^a   Weissmann, Norbert ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a   Ghofrani, Hossein A ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF MUNICH   (Germany)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

biobank; biomarker; etiology subtypes; hypertension; pulmonary; registries; survival

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GERMANY; HEART CATHETERIZATION; HEART TRANSPLANTATION; HUMAN; INFORMED CONSENT; INTERSTITIAL LUNG DISEASE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; SURVIVAL RATE; WALKING; AGE; CAUSE OF DEATH; COMPARATIVE STUDY; HOSPITAL MORTALITY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTOR; SURVIVAL ANALYSIS; TRENDS; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; AGED; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GERMANY; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 85019698880     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2017.02.016     Document Type: Article

References (48)

1. Rubin, L.J., Primary pulmonary hypertension. N Engl J Med 336 (1997), 111–117.
2. Simonneau, G., Robbins, I.M., Beghetti, M., et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 54:suppl (2009), S43–S54.
3. D׳Alonzo, G.E., Barst, R.J., Ayres, S.M., et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115 (1991), 343–349.
4. Rich, S., Dantzker, D.R., Ayres, S.M., et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107 (1987), 216–223.
5. Benza, R.L., Miller, D.P., Gomberg-Maitland, M., et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation 122 (2010), 164–172.
6. Humbert, M., Sitbon, O., Chaouat, A., et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation 122 (2010), 156–163.
7. Humbert, M., Sitbon, O., Chaouat, A., et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 173 (2006), 1023–1030.
8. Appelbaum, L., Yigla, M., Bendayan, D., et al. Primary pulmonary hypertension in Israel: a national survey. Chest 119 (2001), 1801–1806.
9. Barst, R.J., Rubin, L.J., Long, W.A., et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334 (1996), 296–302.
10. Kuhn, K.P., Byrne, D.W., Arbogast, P.G., et al. Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med 167 (2003), 580–586.
11. Miyamoto, S., Nagaya, N., Satoh, T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161 (2000), 487–492.
12. Sandoval, J., Bauerle, O., Palomar, A., et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 89 (1994), 1733–1744.
13. Barst, R.J., McGoon, M., Torbicki, A., et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol, 43(suppl), 2004 40S-7S.
14. Galie, N., Hoeper, M.M., Humbert, M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34 (2009), 1219–1263.
15. von Elm, E., Altman, D.G., Egger, M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61 (2008), 344–349.
16. Rich, S., Primary pulmonary hypertension: executive summary from the World Symposium—Primary Pulmonary Hypertension 1998. 1998, World Health Organization, Evian, France http://web.archive.org/web/20020408173726/. http:/www.who.int/ncd/cvd/pph.html. Accessed March 3, 2017.
17. Barst, R.J., Evaluation and treatment for angina in pulmonary arterial hypertension. Am J Med 116 (2004), 427–428.
18. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002), 111–117.
19. Hurdman, J., Condliffe, R., Elliot, C.A., et al. Aspire Registry: assessing the spectrum of pulmonary hypertension identified at a referral centre. Eur Respir J 39 (2012), 945–955.
20. Cannon, J.E., Su, L., Kiely, D.G., et al. Dynamic risk stratification of patient long-term outcome after pulmonary endarterectomy: results from the United Kingdom National Cohort. Circulation 133 (2016), 1761–1771.
21. Thenappan, T., Shah, S.J., Rich, S., et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 30 (2007), 1103–1110.
22. Fares, W.H., Bellumkonda, L., Tonelli, A.R., et al. Right atrial pressure/pulmonary artery wedge pressure ratio: a more specific predictor of survival in pulmonary arterial hypertension. J Heart Lung Transplant 35 (2016), 760–767.
23. Mueller-Mottet, S., Stricker, H., Domenighetti, G., et al. Long-term data from the Swiss pulmonary hypertension registry. Respiration 89 (2015), 127–140.
24. Chung, W.J., Park, Y.B., Jeon, C.H., et al. Baseline characteristics of the Korean Registry of Pulmonary Arterial Hypertension. J Korean Med Sci 30 (2015), 1429–1438.
25. Humbert, M., Sitbon, O., Yaici, A., et al. Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension. Eur Respir J 36 (2010), 549–555.
26. Alonso-Gonzalez, R., Lopez-Guarch, C.J., Subirana-Domenech, M.T., et al. Pulmonary hypertension and congenital heart disease: an insight from the REHAP National Registry. Int J Cardiol 184 (2015), 717–723.
27. Ling, Y., Johnson, M.K., Kiely, D.G., et al. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland. Am J Respir Crit Care Med 186 (2012), 790–796.
28. Farber, H.W., Miller, D.P., Poms, A.D., et al. Five-year outcomes of patients enrolled in the REVEAL Registry. Chest 148 (2015), 1043–1054.
29. Simonneau, G., Channick, R.N., Delcroix, M., et al. Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN. Eur Respir J 46 (2015), 1711–1720.
30. Jenkins, D.P., Madani, M., Mayer, E., et al. Surgical treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J 41 (2013), 735–742.
31. Farber, H.W., Gibbs, S., Under pressure: pulmonary hypertension associated with left heart disease. Eur Respir Rev 24 (2015), 665–673.
32. Gerges, C., Gerges, M., Lang, M.B., et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in “out-of-proportion” pulmonary hypertension. Chest 143 (2013), 758–766.
33. Naeije, R., Vachiery, J.L., Yerly, P., et al. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 41 (2013), 217–223.
34. Galie, N., Humbert, M., Vachiery, J.L., et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 37 (2016), 67–119.
35. Hurdman, J., Condliffe, R., Elliot, C.A., et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J 41 (2013), 1292–1301.
36. McLaughlin, V., Archer, S.L., Badesch, D.B., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension. J Am Coll Cardiol 53 (2009), 1573–1619.
37. Swiston, J.R., Johnson, S.R., Granton, J.T., Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature. Respir Med 104 (2010), 1588–1607.
38. Rosenkranz, S., Bonderman, D., Buerke, M., et al. Pulmonary hypertension due to left heart disease: updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 154:suppl 1 (2011), S34–S44.
39. Gerges, M., Gerges, C., Pistritto, A.M., et al. Pulmonary hypertension in heart failure. epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med 192 (2015), 1234–1246.
40. Mohammed, S.F., Hussain, I., AbouEzzeddine, O.F., et al. Right ventricular function in heart failure with preserved ejection fraction: a community-based study. Circulation 130 (2014), 2310–2320.
41. Hoeper, M.M., Andreas, S., Bastian, A., et al. Pulmonary hypertension due to chronic lung disease: updated Recommendations of the Cologne Consensus Conference 2011. Int J Cardiol 154(suppl 1) (2011), S45–53.
42. Escribano-Subias, P., Blanco, I., Lopez-Meseguer, M., et al. Survival in pulmonary hypertension in Spain: insights from the Spanish registry. Eur Respir J 40 (2012), 596–603.
43. McLaughlin, V.V., Langer, A., Tan, M., et al. Contemporary trends in the diagnosis and management of pulmonary arterial hypertension: an initiative to close the care gap. Chest 143 (2013), 324–332.
44. Thenappan, T., Shah, S.J., Rich, S., et al. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation. Eur Respir J 35 (2010), 1079–1087.
45. Peacock, A.J., Murphy, N.F., McMurray, J.J., et al. An epidemiological study of pulmonary arterial hypertension. Eur Respir J 30 (2007), 104–109.
46. Delcroix, M., Lang, I., Pepke-Zaba, J., et al. Long-term outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. Circulation 133 (2016), 859–871.
47. Escribano-Subias, P., Del Pozo, R., Roman-Broto, A., et al. Management and outcomes in chronic thromboembolic pulmonary hypertension: from expert centers to a nationwide perspective. Int J Cardiol 203 (2016), 938–944.
48. Condliffe, R., Kiely, D.G., Gibbs, J.S., et al. Improved outcomes in medically and surgically treated chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 177 (2008), 1122–1127.